STUDY THE NEPHRO-PROTECTIVE EFFECTS OF LOSARTAN ON RATS
In the Reduction of Endpoints in NIDDM (noninsulin–dependent diabetes mellitus) with the Angiotensin II Antagonist Losartan study (RENAAL study), Losartan reduced the risk of the doubling of serum creatinine concentration by 25% and of end stage renal disease (ESRD) by 28%. Methods: 40 albino rats...
Na minha lista:
| Autor principal: | |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Al-Azhar University, Faculty of Pharmacy
2014-03-01
|
| coleção: | Al-Azhar Journal of Pharmaceutical Sciences |
| Assuntos: | |
| Acesso em linha: | https://ajps.journals.ekb.eg/article_6967_e6ca9db5c9ac52eb0ee2f696b04017ce.pdf |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|